Solventum Past Earnings Performance
Past criteria checks 1/6
Solventum's earnings have been declining at an average annual rate of -5.8%, while the Medical Equipment industry saw earnings growing at 12.5% annually. Revenues have been growing at an average rate of 0.4% per year. Solventum's return on equity is 22.6%, and it has net margins of 8.8%.
Key information
-5.8%
Earnings growth rate
-47.9%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 0.4% |
| Return on equity | 22.6% |
| Net Margin | 8.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
A Look At The Intrinsic Value Of Solventum Corporation (NYSE:SOLV)
Oct 10
Solventum: No Rush To Buy As Post-Spin Execution Will Take Time To Play Out
Sep 11Solventum (NYSE:SOLV) Has A Pretty Healthy Balance Sheet
Aug 18Solventum: Stumbling Out Of The Gate
Jul 07Solventum Corporation (NYSE:SOLV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Jun 26Solventum: A Reasonable Start, Still Some Questions To Be Asked
May 173M Says Bye To Solventum - Why I Stick To My Bullish Call
Apr 02Revenue & Expenses Breakdown
How Solventum makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 8,215 | 720 | 2,570 | 766 |
| 30 Jun 24 | 8,207 | 1,058 | 2,388 | 757 |
| 31 Mar 24 | 8,202 | 1,290 | 2,266 | 758 |
| 31 Dec 23 | 8,197 | 1,346 | 2,247 | 758 |
| 30 Sep 23 | 8,166 | 1,381 | 2,222 | 754 |
| 30 Jun 23 | 8,101 | 1,256 | 2,240 | 757 |
| 31 Mar 23 | 8,083 | 1,286 | 2,238 | 763 |
| 31 Dec 22 | 8,130 | 1,343 | 2,238 | 767 |
| 31 Dec 21 | 8,171 | 1,460 | 2,282 | 766 |
| 31 Dec 20 | 7,281 | 1,138 | 2,169 | 719 |
Quality Earnings: SOLV has high quality earnings.
Growing Profit Margin: SOLV's current net profit margins (8.8%) are lower than last year (16.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SOLV's earnings have declined by 5.8% per year over the past 5 years.
Accelerating Growth: SOLV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SOLV had negative earnings growth (-47.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (11.7%).
Return on Equity
High ROE: Whilst SOLV's Return on Equity (22.56%) is high, this metric is skewed due to their high level of debt.